MR
MEDIROM Healthcare Technologies Inc.
MRM · NASDAQ
$0.75 -1.33% (-$0.01)
1M -21.06%
Market Cap ¥817.8M
P/E Ratio 5.99x
Div. Yield -
ROE 31.19%
Bulios Fair Price
$0.95
26.7% upside
Current Price
$0.75
Undervalued Fair Value Overvalued
According to Bulios Fair Price, MRM is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
89 /100
Cheap EV/EBITDA 11.47x
P/S 0.10x
P/B 0.88x
Growth
89 /100
Growing Rev. growth 15.33%
FCF growth N/A
Book val. growth N/A
Profitability
13 /100
Weak Net margin 1.79%
Op. margin 0.22%
FCF margin 22.85%
Quality
46 /100
Average ROE 31.19%
ROA 1.84%
Asset turnover 1.03x
Debt
7 /100
High Current ratio 0.65x
Int. coverage 1.96x
Net debt/EBITDA 9.36x
Stability
55 /100
Moderate Rev. volatility 15.90%
EPS volatility 67.70%
Profitable years 3
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about MRM
Online
Sector
Consumer Cyclical
Industry
Personal Products & Services
CEO
Kouji Eguchi
Employees
334
Headquarters
Tokyo